Genomic Health PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ. Exact Sciences Oncotype DX Identifies Postmenopausal Breast Cancer Patients Who Can Forgo Chemo Premium The results, presented at SABCS this week, leave open whether the added benefit from chemo seen in premenopausal women may be due to chemo-induced hormone reduction. Biocartis to Invest in IVD Partnerships Following Termination of Genomic Health Deal Premium The firm will partner with startup GeneproDx on thyroid cancer diagnostic development, while a separate agreement with Endpoint Health will entail CDx development for critical illness. Biocartis, Exact Sciences Terminate Oncotype DX Agreement The firms had planned to develop the assay on Biocartis' Idylla platform, which would have allowed customers to perform the assay locally in their own lab facilities. Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Myriad Genetics' EndoPredict, Agendia's MammaPrint (distributed in Germany by PathoNext), and Veracyte's Prosigna will now be covered by public insurance. Jul 30, 2020 Exact Sciences Q2 Revenues Up 35 Percent, Buoyed by COVID-19 Testing Sales May 31, 2020 Oncotype DX May Be Helpful in Guiding Neoadjuvant Breast Cancer Treatment Decisions Premium May 6, 2020 Exact Sciences Q1 Revenues Up 115 Percent Feb 12, 2020 Exact Sciences Boosting Position in Cancer Dx Market Through M&A Premium Feb 11, 2020 Exact Sciences Q4 Revenues Up 107 Percent Jan 12, 2020 Exact Sciences Preliminary Q4 Revenues Beat Estimates Jan 10, 2020 OncotypeDX Score May Give Valuable Info on Breast Cancer Locoregional Recurrence Nov 22, 2019 Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests Premium Nov 20, 2019 Lower Cutoff Score for Oncotype DX Test May Be Needed for Male Breast Cancer Patients Oct 30, 2019 Genomic Health Q3 Revenues up 11 Percent, Beating Analysts' Expectation Oct 29, 2019 Exact Sciences Q3 Revenues Up 85 Percent Oct 29, 2019 Exact Sciences, Genomic Health Detail Plans for Post-Acquisition Business Structure, Personnel Changes Sep 30, 2019 TAILORx High-Risk Group Analysis Adds to Oncotype DX Chemo-Prediction Data Aug 1, 2019 Illumina Stock Stumbles in July as GenomeWeb Index Sinks 3 Percent Jul 29, 2019 Exact Sciences Touts Advantages of Genomic Health Acquisition for Pipeline Development Premium Jul 29, 2019 Genomic Health Q2 Revenues up 19 Percent as Acquisition by Exact Sciences Looms Jul 29, 2019 Exact Sciences to Acquire Genomic Health for $2.8B; Q2 Revenues Rise 94 Percent Jun 28, 2019 Competing Breast Cancer Assays Beat Genomic Health's Oncotype Dx in Canadian Cost Modeling Study Premium Jun 20, 2019 Germany Agrees to Nationwide Reimbursement for Genomic Health Oncotype DX Breast Cancer Test Jun 20, 2019 Genomic Health Upgraded to Overweight by Piper Jaffray Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.